Treatment with Tocilizumab in Adult Patients with Moderate to Critical COVID‐19 Pneumonia: A Single‐Center Retrospective Study

OBJECTIVES: This study aimed to assess if tocilizumab (TCZ) timing is associated with improved survival. MATERIAL AND METHODS: Data obtained from adult patients with moderate/severe/critical COVID-19 and treated with TCZ, who were admitted to the Teaching Hospital of Infectious Diseases, Cluj-Napoca...

Descripción completa

Detalles Bibliográficos
Autores principales: Radulescu, Amanda, Istrate, Alexandru, Muntean, Monica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8793111/
https://www.ncbi.nlm.nih.gov/pubmed/35093528
http://dx.doi.org/10.1016/j.ijid.2022.01.048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8793111/
https://www.ncbi.nlm.nih.gov/pubmed/35093528
http://dx.doi.org/10.1016/j.ijid.2022.01.048

Ejemplares similares